199 related articles for article (PubMed ID: 12640317)
41. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
Lovell MO; Speeg KV; Havranek RD; Sharkey FE
Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
[TBL] [Abstract][Full Text] [Related]
42. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.
Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies MD; García-Pagán JC; Martí JM; Bosch J
Ann Hematol; 1993 Feb; 66(2):77-80. PubMed ID: 8448243
[TBL] [Abstract][Full Text] [Related]
43. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
[TBL] [Abstract][Full Text] [Related]
44. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb HJ; Holler E; Pihusch R
Bone Marrow Transplant; 2005 Oct; 36(7):631-7. PubMed ID: 16062176
[TBL] [Abstract][Full Text] [Related]
45. Graft Failure From Hepatic Veno-Occlusive Disease After a Liver Transplant: A Case Report.
Shen T; Tang X; Xiang H; Zheng S
Exp Clin Transplant; 2016 Oct; 14(5):575-579. PubMed ID: 25365427
[TBL] [Abstract][Full Text] [Related]
46. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
[TBL] [Abstract][Full Text] [Related]
47. Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.
Hou Y; Tam NL; Xue Z; Zhang X; Liao B; Yang J; Fu S; Ma Y; Wu L; He X
Medicine (Baltimore); 2018 Jun; 97(24):e11076. PubMed ID: 29901618
[TBL] [Abstract][Full Text] [Related]
48. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
Cheuk DK; Wang P; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390
[TBL] [Abstract][Full Text] [Related]
49. Hepatic venous outflow obstruction after piggyback orthotopic liver transplantation.
Perkins J
Liver Transpl; 2006 Jan; 12(1):159-60. PubMed ID: 16498710
[No Abstract] [Full Text] [Related]
50. Hepatic veno-occlusive disease and human herpes virus 7 infection in primary agammaglobulinemia.
Soden JS; Narkewicz MR; Haas JE; Sokol RJ
J Pediatr; 2009 Feb; 154(2):299-302. PubMed ID: 19150678
[TBL] [Abstract][Full Text] [Related]
51. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
[TBL] [Abstract][Full Text] [Related]
52. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
53. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
54. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
55. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
[TBL] [Abstract][Full Text] [Related]
56. Chronic rejection preceded by central perivenulitis, rapidly ensuing after liver transplantation in a pediatric patient.
Miloh T; Magid MS; Iyer K; Kerkar N; Morotti RA
Semin Liver Dis; 2009 Feb; 29(1):134-8. PubMed ID: 19235665
[TBL] [Abstract][Full Text] [Related]
57. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
58. Successful treatment with danhong injection for hepatic veno-occlusive disease.
Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
[TBL] [Abstract][Full Text] [Related]
59. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Pihusch V; Pihusch M; Penovici M; Kolb HJ; Hiller E; Pihusch R
Thromb Res; 2005; 116(3):233-40. PubMed ID: 15935832
[TBL] [Abstract][Full Text] [Related]
60. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
